ESR1 and breast cancer: Although total TILs were not informative in ER+ breast cancers, spatial distribution was predictive of response to anti-estrogen therapies and prognosis, highlighting the importance of heterogeneity of the tumor cells and local microenvironments, including cytokine networks and associated immune cell populations [121].